From the Journals

Artificial sweeteners no help for weight loss: Review


 

FROM CURRENT OPINION IN CARDIOLOGY

Cardiovascular risk factor?

Are artificial sweeteners considered to be a new cardiovascular risk factor? “What they really do is increase the incidence of the other classic risk factors,” including obesity, said Dr. Anguita. It has been shown that artificial sweeteners don’t reduce obesity when used continuously. Nonetheless, “there is still not enough evidence to view it in the same light as the classic risk factors,” added Dr. Anguita. However, it is a factor that can clearly worsen the control of the other factors. Therefore, “it’s appropriate to sound an alarm and explain that it’s not the best way to lose weight; there are many other healthier choices.”

“We need more robust evidence to take a clear position on the use of this type of sweetener and its detrimental effect on health. Meanwhile, it would be ideal to limit their consumption or even avoid adding artificial sweeteners to coffee or teas,” added Dr. Pérez-Martínez.

Regulate consumption

Dr. Pérez-Martínez mentioned that the measures proposed to regulate the consumption of artificial sweeteners and to modify the current legislation must involve “minimizing the consumption of these special dietary products as much as possible and even avoiding adding these artificial sweeteners to the foods that we consume; for example, to coffee and tea.” On the other hand, “we must provide consumers with information that is as clear and simple as possible regarding the composition of the food they consume and how it impacts their health.”

However, “we need more evidence to be able to take a clear position on what type of sweeteners we can consume in our diet and also to what extent we should limit their presence in the foods we consume,” said Dr. Pérez-Martínez.

Last, “most of the evidence is from short-term observational studies that assess frequencies and patterns of consumption of foods containing these artificial sweeteners.” Of course, “we need studies that specifically analyze their effects at the metabolic level as well as longer-term studies where the nutritional follow-up of participants is more accurate and rigorous, especially when it comes to the consumption of this type of food,” concluded Dr. Gómez-Delgado.

This article was translated from the Medscape Spanish Edition. A version appeared on Medscape.com.

Pages

Recommended Reading

Diabetes, cholesterol meds use drops after bariatric surgery
MDedge Cardiology
The road to weight loss is paved with collusion and sabotage
MDedge Cardiology
BMI ‘vastly underestimates’ true obesity
MDedge Cardiology
SURMOUNT-2: Tirzepatide rings up major weight loss in type 2 diabetes
MDedge Cardiology
OASIS and PIONEER PLUS support high-dose oral semaglutide
MDedge Cardiology
Weighing childhood obesity interventions
MDedge Cardiology
Exercise program boosted physical, but not mental, health in young children with overweight
MDedge Cardiology
Obesity cardiomyopathy tied to sudden cardiac death
MDedge Cardiology
Semaglutide cuts cardiovascular events in landmark trial
MDedge Cardiology
‘Water fasting’ benefits don’t last
MDedge Cardiology